KCTD20-JARID2 Fusion FISH Probe
The KCTD20-JARID2 Fusion FISH Probe is used to confirm a fusion of the KCTD20 and JARID2 genes. The fusion of the KCTD20 and JARID2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| KCTD20-JARID2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| KCTD20-JARID2-20-AQAQ | 20 (40 μL) | 200 μL |
|
JARID2 Gene Summary
This gene encodes a Jumonji- and AT-rich interaction domain (ARID)-domain-containing protein. The encoded protein is a DNA-binding protein that functions as a transcriptional repressor. This protein interacts with the Polycomb repressive complex 2 (PRC2) which plays an essential role in regulating gene expression during embryonic development. This protein facilitates the recruitment of the PRC2 complex to target genes. Alternate splicing results in multiple transcript variants. Mutations in this gene are associated with chronic myeloid malignancies. [provided by RefSeq, May 2012]
Gene Name: Jumonji And AT-rich Interaction Domain Containing 2
Chromosome: CHR6: 15246526 -15522253
Locus: 6p22.3
KCTD20 Gene Summary
The Potassium Channel Tetramerization Domain Containing 20 (KCTD20) gene is located on chr6 :36410543-36458315 at 6p21.31.
Gene Name: Potassium Channel Tetramerization Domain Containing 20
Chromosome: CHR6: 36410543 -36458315
Locus: 6p21.31
Gene Diseases
The KCTD20 JARID2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|